Dr. Lal PathLabs Receives Favorable Appellate Order from Income Tax Department
Dr. Lal PathLabs Limited has received a favorable appellate order from the Income Tax Department regarding an assessment order dated March 31, 2024. The company received the appellate order on July 17, 2026, which was issued by the Commissioner of Income Tax (Appeals).The appellate order, dated July 16, 2026, follows an appeal filed by the company against the initial assessment. The authority ruled in favor of the company, allowing a deduction claimed on account of ESOP Expenses.
Key Details of the Appellate Order
| Particulars | Details |
|---|---|
| Name of the authority | Commissioner of Income Tax (Appeals), Income Tax Department |
| Nature and details of the action(s) taken, initiated or order(s) passed | Appellate Order under section 250 of the Income Tax Act, 1961 from Commissioner of Income Tax (Appeals), Income Tax Department |
| Date of receipt of direction or order | July 17, 2026 (03:03 AM - IST) |
| Deduction Allowed | INR 32,66,18,927/- |
The ruling specifically pertains to the deduction claimed on ESOP Expenses amounting to INR 32,66,18,927. The company confirmed that the appeal was allowed and decided in its favor, providing clarity on the prior assessment dispute.
LALPATHLAB Stock Price Movement
Dr. Lal Path Labs Ltd. shares tumbled 2.89% on Friday to settle at ₹1,687.40. The stock shed ₹50.00 during the session with a total turnover of 212,534 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.